{
  "num_tested_probands": 1,
  "num_positive_het_probands": 0,
  "positive_phenotypes": [
    "early developmental delay",
    "motor weakness",
    "intellectual disability",
    "severe progressive encephalopathy",
    "acute liver failure",
    "mild dysmorphic facial features",
    "severe axial hypotonia",
    "hypertonia",
    "dystonic posturing of arms and legs",
    "slight dysmorphic features",
    "severe delay of cognitive and motor development",
    "optic atrophy",
    "acute liver failure (ALF) and metabolic encephalopathy",
    "episodes with decreased awareness",
    "lateral eye deviation",
    "twitching of the eyelids",
    "seizures at the age of six years",
    "protracted course",
    "early onset developmental delay",
    "extra-pyramidal signs",
    "epilepsy",
    "ptosis",
    "hypoglycaemia",
    "valproate induced hepatotoxicity",
    "mitochondrial disorder phenotype"
  ],
  "num_compound_or_double_hets": 1,
  "explanation": {
    "num_tested_probands": "The report consistently refers to a single proband across multiple pages, suggesting only one proband was tested.",
    "num_positive_het_probands": "No explicit mention of heterozygous probands was found in the report.",
    "positive_phenotypes": "Various explicit and inferred phenotypes were mentioned throughout the report, including developmental delay, motor weakness, intellectual disability, and others.",
    "num_compound_or_double_hets": "The report explicitly mentions compound heterozygosity in the WARS2 gene, suggesting one compound heterozygote proband."
  }
}